Bob Martin Clear Wormer 880 Mg Granules For Dogs
Revised: April 2014
AN: 01391/2013
SUMMARY OF PRODUCT CHARACTERISTICS
Name of the veterinary medicinal product
Bob Martin Clear Wormer 880 mg Granules for Dogs
Qualitative and quantitative composition
Each 4 g sachet contains;
Active Substance(s) mg
Fenbendazole 880
For a full list of excipients, see section 6.1
Pharmaceutical form
Granules.
White to off-white granules.
Clinical Particulars
Target Species
Dogs.
Indications for Use, Specifying the Target Species
Bob Martin Clear Wormer is a broad-spectrum anthelmintic for the treatment and control of common roundworms of the gastrointestinal tract.
Contraindications
None.
Special Warnings for Each Target Species
Assess bodyweight as accurately as possible before calculating the dosage.
Special Precautions for Use
Special precautions for use in animals
None
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Direct contact with the skin should be kept to a minimum. Wash hands after use. Avoid inhalation of dust.
Adverse Reactions (Frequency and Seriousness)
None.
Use During Pregnancy, Lactation, or Lay
Not recommended. For the treatment of pregnant dogs consult a veterinary surgeon.
Interaction With Other Medicinal Products, and Other Forms of Interaction
None known.
Amounts to be Administered and Administration Route
Part sachets should not be used.
Routine treatment of adult dogs:
Administer 1g Bob Martin Clear Wormer per 2.2 kg (5 lbs) bodyweight as a single dose (= 100 mg fenbendazole per kg bodyweight).
Practical dosage recommendations:
2.2 to 4.4 kg
(5-10 lbs) 2 grams
4.5 to 8.8 kg (10-20 lbs) 4 grams
8.9 to 13.2 kg (20-30 lbs) 6 grams
13.3 to 22 kg (30-50 lbs) 10 grams
22.1 to 35.2 kg (50-80 lbs) 16 grams
35.3 to 50 kg (80-110 lbs) 22 grams
For dogs weighing over 50 kg (110 lbs) an extra 1g is required for each additional 2.2 kg bodyweight. The dose should be administered by mixing in the feed.
Treatment should be repeated when natural re-infection with parasitic worms occurs. Routine treatment of adult animals with minimal exposure to infection is advisable 2 to 4 times per year. More frequent treatment at 6-8 weekly intervals is advisable for dogs in kennels.
Weaned puppies under six months of age:
Administer 1g Bob Martin Clear Wormer per 4.4 kg (10 lbs) bodyweight daily for 3 consecutive days mixed into the feed (= 50 mg fenbendazole per kg bodyweight for 3 days).
Practical dosage recommendations:
2.2 to 4.4 kg (5-10 lbs) 1 gram daily for 3 days
4.4 to 8.8 kg (10-20 lbs) 2 grams daily for 3 days
8.8 to 13.2 kg (20-30 lbs) 3 grams daily for 3 days
13.3 to 22 kg (30-50 lbs) 5 grams daily for 3 days
For dogs/puppies weighing over 22 kg (50 lbs), an extra 1g is required daily for each additional 4.4 kg (10 lbs) bodyweight.
Small or unweaned puppies should be treated with a suitable licensed product up to 12 weeks of age.
Puppies should be treated at 2 weeks of age, 5 weeks of age and again before leaving the breeder’s premises. Further treatments are recommended at 8 and 12 weeks of age. Thereafter, frequency of treatment can be reduced unless the pups remain in kennels where infection occurs more readily
Overdose (Symptoms, Emergency Procedures, Antidotes), If Necessary
No treatment specified. Benzimidazoles have a wide safety margin.
Withdrawal Period
Not applicable.
pharmacological properties
Pharmacotherapeutic group: Anthelmintic
ATC Vet Code: QP52AC13
Pharmacodynamic Properties
Fenbendazole, [5-phenylthio)-2-benzimidazole-carbamic] acid methyl ester, belongs to the broad-spectrum anthelmintic class of compounds, the benzimidazoles.
Fenbendazole is believed to act by irreversibly inhibiting glucose uptake by the parasites resulting in depletion of the parasites energy sources, glycogen and ATP, and their consequent death and expulsion.
A relationship exists between plasma concentrations of active anthelmintic metabolites, the duration of high plasma metabolite concentrations and anthelmintic efficacy.
Oxfendazole is a sulphoxide identical to the sulphoxide metabolite of fenbendazole, both are known to be anthelmintically active and metabolically interconvertible.
Much of fenbendazole’s anthelmintic activity is attributed to oxfendazole, the latter being more potent.
Pharmaceutical particulars
List of Excipients
Povidone K30
Maize Starch
Lactose
Incompatibilities
None known.
Shelf Life
Shelf life of the veterinary medicinal product as packaged for sale: 4 years
Special Precautions for Storage
Do not store above 25°C.
Nature and Composition of Immediate Packaging
Carton containing 4 x 4g or 70 x 4g sachets composed of paper/aluminium/low density polyethylene.
Not all pack sizes may be marketed.
Special Precautions for the Disposal of Unused Veterinary Medicinal Product or Waste Materials Derived from the Use of Such Products
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
MARKETING AUTHORISATION HOLDER
Norbrook Laboratories Limited
Station Works
Camlough Road
Newry
Co. Down
BT35 6JP
Northern Ireland
MARKETING AUTHORISATION NUMBER
Vm: 02000/4386
DATE OF FIRST AUTHORISATION
Date:16 January 2002
DATE OF REVISION OF THE TEXT
Date: April 2014
03 April 2014
Page 5 of 5